FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

UK Unveils Plan for Investment in Life Sciences

Dec. 1, 2017

The UK government announced a long-term strategy for the nation’s industries, including a multi-billion pound initiative to boost investment in the life sciences sector.

MSD, known as Merck & Co. in the U.S., signed on to the plan this week by pledging to open a new state-of-the-art research hub in the UK, supporting over 950 jobs.

Additionally, Qiagen announced plans to develop a genomics and diagnostics campus in Manchester, in partnership with the local government, universities and academic health system. The UK government’s report on the investment plan also points to a £115 million investment from Novo Nordisk in an Oxford diabetes research center earlier this year.

View today's stories